- Adults (18-64 years)
- General population
- Hospital
- Monkeypox virus
- Mpox
- Blood sample
- Vaccination
- MVA-BN
Central Data Repository
Explore the Central Data Repository: Use the filters and keyword search box on the left to find relevant studies. As you refine your search, the map and study list will automatically update to reflect your selections. Selecting a study from the list will provide detailed information about the specific study in question. A full legend can be found here
{content}
Study list
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Community
- SARS-CoV-2
- Post COVID-19 condition
- Non pharmacological intervention
- Rehabilitation
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Primary care
- SARS-CoV-2
- Post COVID-19 condition
- Non pharmacological intervention
- Rehabilitation
- Physical activity
- General population
- Infants (<1 year)
- Children (1-11 years)
- Hospital
- Emergency department
- Respiratory syncytial virus
- Respiratory syncytial virus infection
- General population
- Infants (<1 year)
- Children (1-11 years)
- Hospital
- Emergency department
- Respiratory syncytial virus
- Respiratory syncytial virus infection
- Adults (18-64 years)
- General population
- Hospital
- Chlamydia trachomatis
- Neisseria gonorrhoeae
- Mycoplasma genitalium
- Trichomonas vaginalis
- Sexually transmitted infection
- Non pharmacological intervention
- RT-PCR
- Adults (18-64 years)
- General population
- Non-hospital health centre
- Vaccination centre
- Monkeypox virus
- Mpox
- Pharmacological intervention
- Vaccination
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Emergency department
- SARS-CoV-2
- Respiratory syncytial virus
- Influenza virus
- Respiratory syncytial virus infection
- Influenza
- COVID-19
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- SARS-CoV-2
- Post COVID-19 condition
- Non pharmacological intervention
- Dietary
- Probiotic
- Adults (18-64 years)
- Elderly (≥65 years)
- Outpatient clinic
- SARS-CoV-2
- Post COVID-19 condition
- Non pharmacological intervention
- Dietary
- Lifestyle
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Community
- Primary care
- SARS-CoV-2
- Post COVID-19 condition
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Outpatient clinic
- SARS-CoV-2
- Post COVID-19 condition
- Non pharmacological intervention
- Plasma exchange
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Outpatient clinic
- SARS-CoV-2
- Post COVID-19 condition
- Non pharmacological intervention
- Rehabilitation
- Neuromodulation
- Adults (18-64 years)
- People at high risk of STIs
- Outpatient clinic
- Non-hospital health centre
- STD/STI clinic
- Monkeypox virus
- Mpox
- Blood sample
- Adults (18-64 years)
- General population
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Post COVID-19 condition
- Adults (18-64 years)
- People at high risk of STIs
- Hospital
- Outpatient clinic
- Monkeypox virus
- Mpox
- Pharmacological intervention
- Vaccination
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Community
- SARS-CoV-2
- Post COVID-19 condition
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Outpatient clinic
- SARS-CoV-2
- Post COVID-19 condition
- Pharmacological intervention
- Monoclonal antibodies
- Temelimab
- Adults (18-64 years)
- General population
- Outpatient clinic
- SARS-CoV-2
- Post COVID-19 condition
- Non pharmacological intervention
- Immunoadsorption
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- SARS-CoV-2
- Post COVID-19 condition
- Non pharmacological intervention
- Rehabilitation
- Fragile population
- Infants (<1 year)
- Hospital
- Respiratory syncytial virus
- Respiratory syncytial virus infection
- Pharmacological intervention
- Monoclonal antibodies
- Palivizumab
- Adults (18-64 years)
- Elderly (≥65 years)
- People at high risk of STIs
- Men who have sex with men
- Healthcare workers
- Hospital
- Infectious diseases unit
- Monkeypox virus
- Mpox
- Pharmacological intervention
- Vaccination
- MVA-BN
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Acute COVID-19
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Molnupiravir
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Monkeypox virus
- Mpox
- Pharmacological intervention
- Antivirals
- Tecovirimat